Back to search results

Philly CEAL- DECIDE+ Adaptation for Cardiovascular Health

This study is looking at how to improve heart health (cardiovascular disease or CVD) in Philadelphia, especially for groups that are often overlooked. It's testing a program called DECIDE+ which combines a self-management education program (DECIDE) with support from Community Health Workers (CHWs). The goal is to see if this combined approach helps people better manage their CVD and address social needs that affect their health. You might be able to join if you live in Philadelphia, are between 35 and 75 years old, and have been told by a doctor that you have conditions like pre-diabetes, diabetes, high blood pressure (hypertension), high cholesterol (hyperlipidemia), or a BMI of 30 or higher. The study aims to enroll 500 people and will measure how well participants manage their CVD over 6 months.

Study design
This study plans to enroll 500 participants. It uses a Type 1 Hybrid Effectiveness-Implementation Design, meaning it looks at both how well the intervention works and how it can be put into practice.
What's involved
Participants will either receive the DECIDE+ intervention, which includes 9 bi-weekly group sessions and alternating CHW consultations, or continue with standard CHW services. The study measures outcomes over a 6-month period.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months after enrollment to measure their CVD self-management skills.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06732102

Philly CEAL- DECIDE+ Adaptation

Recruiting
NAAges 35–75InterventionalTreatment
University of Pennsylvania
~500 participants
Updated 2025-10-01 on ClinicalTrials.gov
What's tested:DECIDECommunity Health Worker Support

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
CVD Self-Management Skills
Measured over From enrollment to the end of follow-up period at 6 months

Conditions

Disparities
Community Health Workers
Cardiovascular Diseases
Social Determinants of Health (SDOH)

Explore related trials

Cardiovascular DisorderDiabetes MellitusHyperlipidemiaHypertensionObesityPrediabetes

Where it's being run

1 sites across 1 states
Pennsylvania1

Study leadership

  • Jose Bauermeister, MPH, PhD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania
  • Antonia Villarruel, RN, PhD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania
  • Carmen Alvarez, RN, PhD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania
  • Stephen Bonett, RN, PhD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania
  • Ashley Clemmons · PRINCIPAL_INVESTIGATOR · Office of Community Empowerment and Opportunity

Who to contact

Jose Bauermeister, MPH, PhD
[email protected]
215-898-9993
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Reside in Philadelphia
Be between 35 and 75 years of age (inclusive)
Self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions:
Have completed an initial visit with a CEO CHW
Have one or more unmet social needs identified in the CEO Intake Form in the following areas:
Willing to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment.

Exclusion

Does not reside in Philadelphia
Not between 35 and 75 years of age (inclusive)
Does not self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions:
Has not completed an initial visit with a CEO CHW
Does not have one or more unmet social needs identified in the CEO Intake Form in the following areas:
Unwilling to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment.

What this trial measures

  • CVD Self-Management SkillsFrom enrollment to the end of follow-up period at 6 months

    CVD self-management skills, measured by the Self-care of Chronic Illness Inventory Maintenance scale (SC-CII Maintenance).(Riegel et al., 2018) This 8-item measure of self-care maintenance assesses the degree to which an individual with chronic illness uses various strategies to maintain physical and emotional stability and includes both health promoting behaviors and illness-related behaviors. The scale is scored by summing the responses on the eight items and dividing by the total possible points to create a scale ranging from 0-1, where higher scores indicate better self-care maintenance.